INCELL Inside
  • Product Line
  • Reg Med
    • Cell & Tissue Products
      • Regenerative & Stem Cells
      • Tissue-Derived Products
      • Reagents & Testing
      • INCELL Established Cell Lines
    • Tissue Collections & Kit Products
    • Storage of Cell & Tissue Products
    • Services: Manufacturing , Testing and R&D
      • Accelerated Product Development Services
      • Regenerative & Stem Cell Products
  • Micro
    • Microbiology & Vaccine Products
      • Microbiology Testing
        • Sterility: GMP and USP Compliant
        • Microbial Bioburden
        • Endotoxin/Pyrogen Testing
        • Mycoplasma Testing
        • Antimicrobial & Microbiological Testing
    • Vaccines and Microbiology Products
      • Microbiology & Vaccines Collaborations
    • Clinical Studies
  • Clinical
    • Clinical Trials
    • Personalized Medicine
  • About
    • Corporate
      • Contact
      • History
      • Mission
      • Registration, Licenses & Certificates
      • Memberships, Boards and Committees
    • Organization & Management
      • Board Members
        • Executive Managers
      • Key Alliances
        • Collaborative Business Model
    • Business Units & Activities
      • Regenerative Medicine
      • Media, Solutions & Kits
      • Microbiology & Vaccine Products
  • FAQ
  • News
    • Blog
    • Social Media
    • News & Newsworthy
      • Press Releases
      • Announcements
      • Community & Service Activities
        • Current Boards & Outreach
        • Archives
      • White Papers & Publications
        • White Papers
        • Publications & Links
      • Presentations
        • Recent
        • Archives
  • Jobs

Recent Posts

  • Letter from INCELL’s CEO
  • Dr. Mary Pat Moyer inducted to the National Academy of Engineering for her contribution to regenerative medicine, October 2019
INCELL is a products manufacturer and contract services provider with the mission to provide "Innovative Life Science Solutions™" in biomedicine.

Microbiology & Vaccines Collaborations

INCELL’s collaborative business model and unique capabilities have led to participation in multiple projects, contracts and grants related to infectious disease, vaccines, and biodefense.

The intended acceleration of commercial vaccine and microbiology products development involve important planning, Quality by Design (QbD), development and logistics in all activities and steps.

vaccine-planning

Several current projects are targeted at new treatments for acute infections and new anti-bacterial compounds that are effective against drug-resistant and high consequence human pathogens such as MRSA, pneumonia and nosocomial infections. Other work is focused on new diagnostics tools and tests.

Funding has come primarily from NIH and DoD grants or contracts directly, or indirectly via subcontracts from other companies or academic entities. As examples, expertise relevant to translational research was provided by INCELL as a member of the NIH Western Regional Center of Excellence for biodefense products development, and the Product Development Working Group, tasked with new product development and testing of vaccines, components and biotechnology-derived products.

Current collaborative, non-confidential biodefense bacterial vaccines work is focused on Brucella and Coxiella. Brucella is the causative agent of brucellosis and Coxiella causes Q fever. The Brucella work is a collaboration with university Professors, Drs. Thomas Ficht and Allison Rice-Ficht at Texas A&M University College of Veterinary Medicine and Health Science Center. Coxiella vaccine work is in collaboration with Dr. James Samuels, Professor at Texas A&M Health Science Center. INCELL is currently provided consulting on specialized platforms and approaches, as well as practical considerations for product design, packaging, marketing, intellectual property and requirements of product development and GMP manufacturing.

INCELL Collaborations

Product Categories

  • Collection, Transport and Processing Solutions
  • Compounded Drugs
  • Cryopreservation Media
    • EZ-CPZ ™ Cryopreservation Media Family
  • Culture Media
    • M3™ Media Family
  • Place Order
  • Proprietary Cell Lines
  • Sample Category
  • Services
  • Special Order
  • Tissue Collection Kits
  • Uncategorized

Recent Posts

  • Letter from INCELL’s CEO
  • Dr. Mary Pat Moyer inducted to the National Academy of Engineering for her contribution to regenerative medicine, October 2019
  • Dr. Moyer Addresses Orthopedic Physicians at AAOM National Meeting
  • INCELL Global Expansion
  • INCELL Sponsors WSCS in December 2016

Contact INCELL Corporation LLC

12734 Cimarron Path (Directions)
San Antonio, Texas 78249
Tel: 210-877-0100|Toll-free: 800.364.1765
Fax: 210-877-0200

Search Downloads

Privacy Policy | Sitemap | Contact

Copyright © 1993 - 2023. All Rights Reserved.

Designed by WebAuthorings.